{"container_type": "Publication", "source": "AUTHOR_PUBLICATION_ENTRY", "bib": {"title": "Rational design, synthesis and testing of novel tricyclic topoisomerase inhibitors for the treatment of bacterial infections part 2", "pub_year": 2020, "citation": "RSC Medicinal Chemistry 11 (12), 1379-1385, 2020", "author": "R Kirk and A Ratcliffe and G Noonan and M Uosis-Martin and D Lyth and O Bardell-Cox and J Massam and P Schofield and A Lyons and D Clare and J Maclean and A Smith and V Savage and S Mohmed and C Charrier and AM Salisbury and E Moyo and N Ooi and N Chalam-Judge and J Cheung and NR Stokes and S Best and M Craighead and R Armer and A Huxley", "journal": "RSC Medicinal Chemistry", "volume": "11", "number": "12", "pages": "1379-1385", "publisher": "Royal Society of Chemistry", "abstract": "Building on our previously-reported novel tricyclic topoisomerase inhibitors (NTTIs), we disclose the discovery of REDX07965, which has an MIC90 of 0.5 \u03bcg mL\u22121 against Staphylococcus aureus, favourable in vitro pharmacokinetic properties, selectivity versus human topoisomerase II and an acceptable toxicity profile. The results herein validate a rational design approach to address the urgent unmet medical need for novel antibiotics."}, "filled": true, "author_pub_id": "mSp4V_4AAAAJ:moa2YIFg52oC", "num_citations": 1, "citedby_url": "/scholar?hl=en&cites=17836051201220345424", "cites_id": ["17836051201220345424"], "pub_url": "https://pubs.rsc.org/en/content/articlehtml/2020/md/d0md00175a", "url_related_articles": "/scholar?oi=bibs&hl=en&oe=ASCII&q=related:UP5qbBFihvcJ:scholar.google.com/", "cites_per_year": {"2022": 1}}